Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

HPV-Associated Oropharyngeal Squamous Cell Carcinoma · HPV Positive Oropharyngeal Squamous Cell Carcinoma · HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Stage · HPV-Related Squamous Cell Carcinoma · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Clinical Stage · HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Pathologic Stage

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Brigham and Women's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Jonathan Schoenfeld, MD, MPH) · jonathan_schoenfeld@dfci.harvard.edu · 617.632.5296
    Contact: Principal Investigator (Jonathan Schoenfeld, MD, MPH)
  • Dana Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Jonathan D. Schoenfeld, MD, MPH) · jonathan_schoenfeld@dfci.harvard.edu · 617.632.5296
    Contact: Principal Investigator (Jonathan D. schoenfeld, MD)
מובילי המחקר
  • Jonathan D Schoenfeld, MD, MPH

    Principal Investigator

    Dana-Farber Cancer Institute